1. THU0110 Affinity and potency of the anti-NKG2A MAB NNC141-0100: Implications for mabel and dosing in the first-in-man trial in rheumatoid arthritis. (23rd January 2014) Authors: Alifrangis, L.; André, P.; Pascal, V.; Bonnet, E.; Radzikowski, L.; Petersen, M.B.; Bléry, M. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗